John Paulson started to build up the position in Esperion Therapeutics in Q4 2015 and continued to invest until Q1 2017. Since then they sold 232 Thousand shares. The investor completely sold their stake between Q2 2017 and Q3 2017.
Avg closing price
Price range
Sold -211 Thousand shares
Q3 2017
Avg closing price
$48.22
Price range
$43.80
-
$52.77
Sold 9.2% shares (-21.3 Thousand shares)
Q2 2017
Avg closing price
$36.77
Price range
$31.53
-
$48.28
Increased shares by 127.3% (+130 Thousand shares)
Q1 2017
Avg closing price
$22.90
Price range
$10.97
-
$41.22
Increased shares by 353.3% (+79.5 Thousand shares)
Q1 2016